Latest filing published 25 Sept 2026 for Oramed Pharmaceuticals INC.. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Miriam Kidron, listed as senior executive, has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Oramed Pharmaceuticals Inc. and Lifeward Ltd. We count 18 filings; the first trade dates from 31 August 2021 and the latest from 24 September 2026.
Every open-market trade on record is a sale: 1 sale worth €187k. Besides market trades, the filings include 15 share grants and 1 option exercise.
The newest entry dates from 25 September 2026: a share grant, in Oramed Pharmaceuticals Inc. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
18 of 18 declarations